Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02CSU
|
||||
Former ID |
DNC004706
|
||||
Drug Name |
4-Indan-(1Z)-ylidenemethyl-pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527456] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H13N
|
||||
Canonical SMILES |
C1CC(=CC2=CC=NC=C2)C3=CC=CC=C31
|
||||
InChI |
1S/C15H13N/c1-2-4-15-13(3-1)5-6-14(15)11-12-7-9-16-10-8-12/h1-4,7-11H,5-6H2/b14-11-
|
||||
InChIKey |
ZHGWOEHABOMOSV-KAMYIIQDSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527456] | |
17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [527456] | ||
Cytochrome P450 19 | Target Info | Inhibitor | [527456] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
WikiPathways | Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
Steroid Biosynthesis | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Tryptophan metabolism | |||||
Ovarian Infertility Genes | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compounds | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.